Noldus announces collaboration agreement with Inscopix

Noldus announces collaboration agreement with Inscopix

June 28, 2022

Noldus Information Technology, a leading developer of tools for behavioral research, announced a collaboration agreement with neuroscience company Inscopix. 

Through this collaboration, Noldus’ pioneering EthoVision XT video tracking software can be integrated in Inscopix’s new nVision platform. Researchers will now be able to perform precise time correlations between rodent brain activity and behavior, such as exploration or navigation and choice tasks. 

“Uncovering brain dysfunction at the neurocircuitry level and how it is linked to behavior will enable researchers to uncover new insights into how the brain works and will support the development of better targeted treatments,” said Lucas Noldus, Ph.D., CEO of Noldus Information Technology. “We are excited to collaborate with Inscopix and offer users the capability of integrating our pioneering video tracking technology with Inscopix’s new platform.”  

EthoVision XT has a long-standing record as the market leading software for video tracking and experiment automation. It is capable of tracking and analyzing animal behavior, movement, and activity from video or live camera input.

Inscopix-Noldus-collaboration-mouse-track

nVision platform

Inscopix’ new nVision platform allows for the real-time integration of behavior with miniscope imaging, which enables the simultaneous capture of high-quality behavior and calcium imaging movies in a single session. “We have been working in the background for a long time now to provide our miniscope users with an effortless and accurate way to synchronize their valuable miniscope data with third party-acquired behavioral movies, which is technically laborious to do and prone to data loss,” said Kunal Ghosh, Ph.D., CEO of Inscopix. “We're thrilled to be introducing nVision, which is the first and only platform enabling both high-resolution acquisition of behavioral videos and precise synchronization with calcium imaging data.”

Upon release, nVision would be the only integrated technology for the two methods during free behavior, providing scientists with unique, synchronized insights into brain health and disease.